Johnson & Johnson Releases 2018 Health for Humanity Report
June 5, 2019 - Johnson & Johnson (NYSE: JNJ), the world’s largest and most broadly-based healthcare company, today released its Health for Humanity Report detailing the Company’s annual progress in its environmental, social and governance (ESG) focus areas: advancing better health for all, investing in our people, maintaining responsible business practices, and safeguarding the environment.
Looking across all Johnson & Johnson’s business practices, the Company shares important disclosures about how it supports good health for patients, consumers, employees and local communities on a global scale. The report tracks how Johnson & Johnson is striving to eradicate and prevent disease, reimagine how care is delivered, and put a healthy mind, body and environment within reach of all people around the world.
The following reflect 2018 highlights:
Better Health for All:
- Initiated first ever large-scale efficacy study for an investigational mosaic HIV-1 preventive vaccine being conducted in five southern African countries together with partners like the National Institutes of Health, the HIV Vaccine Trials Network, the Bill & Melinda Gates Foundation and the South African Medical Research Council, among many others.
- Announced a comprehensive partnership with the Rwanda Ministry of Health to strengthen and expand access to quality mental healthcare in the country.
- Trained 104,479 health workers in essential skills-building and leadership development across 67 countries to deliver better quality of care.
- Expanded partnership with UNICEF with a $10 million pledge to support the crucial work of frontline health workers in delivering care to newborns, children and mothers around the world.
- Trained 77,732 employees in the principles of ENERGY FOR PERFORMANCE, a training program developed by Johnson & Johnson HUMAN PERFORMANCE INSTITUTE.
- Re-imagined hiring at Johnson & Johnson to allow for greater transparency, improved efficiency and a stronger candidate experience through new platforms.
Responsible Business Practices:
- Co-led development of connect4children (c4c), a project to create a pan-European clinical trial network by 2024 to facilitate the conduct of pediatric clinical trials in the EU.
- Advanced to “Trendsetter” status on the Center for Political Accountability’s CPA-Zicklin Index, which the organization deems as those companies most transparent.
- Toward the Health for Humanity Goal of reducing absolute carbon emissions by 20% by 2020, reduced carbon emissions by 26% globally since 2010 (Scope 1 and Scope 2). Johnson & Johnson Consumer Inc. became a signatory to the New Plastics Economy Global Commitment, committing to use more recycled materials in packaging, reduce reliance on single-use packages and ensure that 100% of plastic packaging be reusable, recyclable or compostable by 2025.
To watch a short video-summary of our progress in 2018, click here.
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities, and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.